These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16364852)

  • 1. Elevated donor troponin levels are associated with a lower frequency of allograft vasculopathy.
    Miller WL; Edwards BS; Kremers WK; Kushwaha SS; McGregor CG; Daly RC; Jaffe AS
    J Heart Lung Transplant; 2005 Dec; 24(12):2075-8. PubMed ID: 16364852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients.
    Kittleson MM; Bead V; Fradley M; St John ME; Champion HC; Kasper EK; Russell SD; Wittstein IS; Hare JM
    J Heart Lung Transplant; 2007 May; 26(5):498-503. PubMed ID: 17449420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality.
    Arora S; Jenum PA; Aukrust P; Rollag H; Andreassen AK; Simonsen S; Gude E; Fiane AE; Geiran O; Gullestad L
    J Am Coll Cardiol; 2007 Nov; 50(20):1967-72. PubMed ID: 17996562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor cardiac troponin I levels do not predict recipient survival after cardiac transplantation.
    Khush KK; Menza RL; Babcock WD; Zaroff JG
    J Heart Lung Transplant; 2007 Oct; 26(10):1048-53. PubMed ID: 17919626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation.
    Arora S; Gullestad L; Wergeland R; Simonsen S; Holm T; Hognestad A; Ueland T; Geiran O; Andreassen A
    Transplantation; 2007 May; 83(10):1308-15. PubMed ID: 17519779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation.
    Mahle WT; Vincent RN; Berg AM; Kanter KR
    J Heart Lung Transplant; 2005 Jan; 24(1):63-6. PubMed ID: 15653381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac troponin levels in asymptomatic patients on the renal transplant waiting list.
    Roberts MA; MacMillan N; Hare DL; Ratnaike S; Sikaris K; Fraenkel MB; Ierino FL
    Nephrology (Carlton); 2006 Oct; 11(5):471-6. PubMed ID: 17014564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomography and highly sensitivity troponin T for evaluating cardiac allograft vasculopathy.
    Garrido IP; García-Lara J; Pinar E; Pastor-Pérez F; Sánchez-Mas J; Valdés-Chavarri M; Pascual-Figal DA
    Am J Cardiol; 2012 Sep; 110(5):655-61. PubMed ID: 22640973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy.
    Martínez-Dolz L; Almenar L; Reganon E; Vila V; Chamorro C; Andrés L; Martínez-Sales V; Moro J; Agüero J; Sánchez-Lázaro I; Salvador A
    J Heart Lung Transplant; 2008 Jul; 27(7):760-6. PubMed ID: 18582806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy.
    Soleimani B; Fu F; Lake P; Shi VC
    J Heart Lung Transplant; 2008 Apr; 27(4):450-6. PubMed ID: 18374883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of traditional cardiovascular risk factors in the recipient on the development of cardiac allograft vasculopathy after heart transplantation.
    Sánchez Lázaro IJ; Almenar Bonet L; Moro López J; Sánchez Lacuesta E; Martínez-Dolz L; Agüero Ramón-Llín J; Andrés Lalaguna L; Cano Pérez O; Ortiz Martínez V; Buendía Fuentes F; Salvador Sanz A
    Transplant Proc; 2008 Nov; 40(9):3056-7. PubMed ID: 19010192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy.
    Tambur AR; Pamboukian S; Costanzo MR; Heroux A
    J Heart Lung Transplant; 2006 Jun; 25(6):690-8. PubMed ID: 16730575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility.
    Costanzo-Nordin MR
    J Heart Lung Transplant; 1992; 11(3 Pt 2):S90-103. PubMed ID: 1623009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation.
    Raichlin E; Edwards BS; Kremers WK; Clavell AL; Rodeheffer RJ; Frantz RP; Pereira NL; Daly RC; McGregor CG; Lerman A; Kushwaha SS
    J Heart Lung Transplant; 2009 Apr; 28(4):320-7. PubMed ID: 19332257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy.
    Bayliss J; Bailey M; Leet A; Stein AN; Thomson NM; McLean CA
    Transplantation; 2008 Oct; 86(7):991-7. PubMed ID: 18852667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum troponin Ic values in organ donors are related to donor myocardial dysfunction but not to graft dysfunction or rejection in the recipients.
    Boccheciampe N; Audibert G; Rangeard O; Charpentier C; Perrier JF; Lalot JM; Voltz C; Strub P; Loos-Ayav C; Meistelman C; Mertes PM; Longrois D
    Int J Cardiol; 2009 Mar; 133(1):80-6. PubMed ID: 18255177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease.
    Jonas M; Fang JC; Wang JC; Giri S; Elian D; Har-Zahav Y; Ly H; Seifert PA; Popma JJ; Rogers C
    J Am Coll Cardiol; 2006 Aug; 48(3):453-61. PubMed ID: 16875968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
    Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
    Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
    Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvascular thrombosis and cardiac allograft vasculopathy in rat heart transplantation.
    Labarrere CA; Ortiz MA; Ruzmetov N; Sosa MJ; Campana G; Terry C; Baldridge LA; Antonopoulos R; DiCarlo HL
    J Heart Lung Transplant; 2006 Oct; 25(10):1213-22. PubMed ID: 17045934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.